This application relates to oxygen flow control systems for emergency oxygen supply systems in passenger aircraft.
Emergency oxygen supply systems for passenger aircraft are well known and characterized by being able to provide to each passenger a supply of oxygen in the case of an emergency. These systems are designed to be used during cabin depressurization and thus are intended to supply each passenger with a sufficient oxygen flow to meet the physiological requirements for high-altitude survival.
In the past the main emphasis in development has been directed towards improved breathing apparatus, improved oxygen generation, or accurate delivery of oxygen to meet physiological requirements.
U.S. Pat. No. 6,244,540 issued to Stabile teaches a method for calculating the oxygen required after emergency cabin decompression, but is a relatively complex system that provides constant monitoring of altitude.
U.S. Pat. No. 5,709,204 issued to Lester discloses a specially designed escape mask, but does not recognize the problem of cabin depressurization and the need to charge the system quickly with oxygen using a pneumatic control system.
U.S. Pat. No. 5,809,999 issued to Lang teaches an emergency oxygen supply system of an aircraft equipped with a pressurized cabin, breathable gas is supplied by a gas generator (1) for generating an oxygen-enriched gas either from the ambient air, or from air tapped from the engine whereby passengers receive mixed gas having an adequate oxygen content. This system is complex and requires power during operation.
Therefore, what is needed in the art is an emergency oxygen supply system that is simple and responds to changes in altitude without external monitoring.
Further what is needed in the art is an emergency oxygen supply system that recognizes cabin depressurization and quickly charges the system with oxygen.
Even further what is needed in the art is an emergency oxygen supply system that doesn't require power to regulate oxygen flow after activation.
A central control valve unit is provided for a multiple passenger emergency oxygen system that is pneumatically controlled and provides oxygen to the passengers and crew as a function of altitude. In the event of an emergency de-pressurization of the passenger cabin an emergency oxygen supply will be activated that provides each passenger with a source of oxygen. The amount of oxygen that a passenger requires in order to remain conscious depends upon and is inversely related to the altitude of the plane. At high altitudes the passenger will require more oxygen to compensate for the lower level of oxygen available in the cabin. In order to provide the oxygen quickly, the distribution lines running to the passengers must be purged of the ambient air (that contains only the normal amount of oxygen) and replaced with pure oxygen. After the system has been purged the lines are then supplied with the altitude dependent supply of oxygen.
The central flow control valve system (CFCV) is operated by pneumatic means after it is activated to simplify the system and reduce the amount of electrical power required to operate. After activation, the system locks mechanically in operating mode until the system is reset, thus insuring operation throughout the emergency without need to draw further electrical power. The CFCV provides a simple subsystem that automatically charges the distribution lines with oxygen, and then operates without further electrical power requirements to supply the human physiological oxygen requirement at effective altitude. This supply requirement is achieved in a two phase system; increased oxygen supply from 10,000 to 15,000 feet, and a more rapidly increasing oxygen/altitude supply rate increase at above about 15,000 feet.
The above-mentioned and other features and advantages of this invention, and the manner of attaining them, will become appreciated and be more readily understood by reference to the following detailed description of one embodiment of the invention in conjunction with the accompanying drawings, wherein:
Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate the preferred embodiments of the invention and such exemplifications are not to be construed as limiting the scope of the invention in any manner.
Referring now to
The CFCV (10) is kept inactive until activated by either a person or an automatic sensor. Then the CFCV (10) operates to provide a full pressure purge of the distribution lines (6) in order to replace the ambient air with oxygen. Typically the purge is done by allowing relatively unrestricted flow of the oxygen through the CFCV (10) from the source manifold for a period of about 5 seconds (although the amount of time will depend upon the volume of the distribution system). This surge of pressure also serves to unlatch the mask container doors in the multiple individual user stations (7).
After purging the system the CFCV (10) then regulates the oxygen flow as a function of pressure within the passenger cabin. If de-pressurization has occurred due to a compromise of the pressure cabin integrity, the CFCV (10) will adjust the pressure of the oxygen supply to exceed the minimum physiological requirement for the altitude equivalent of the prevailing cabin pressure. In general, the physiological oxygen requirement follows the curve shown in
A small orifice (39) in the central axis of the diaphragm (25) communicates between a first pressure chamber (26) and said second pressure chamber (27) and as time passes the pressure between the chambers equalizes. At relatively low altitudes the altitude aneroid (30) opens the bleed valve (29) of the second chamber (27), and the diaphragm (25) reacts to lower the outlet pressure. At higher altitudes the altitude aneroid (30) expands and closes the bleed valve (29) and the diaphragm (25) maintains the regulating valve (22) in a relatively more open position allowing greater oxygen pressures and flows.
Of course, the system operates in such a fashion that the system is not completely open or closed in operation and meets or exceeds the physiologically required oxygen flow at the particular pressure of the cabin. This regulation is continuous and after activation operates pneumatically.
Referring now to
Resetting of the CFCV (10) is achieved when an electronic reset signal of 28 VDC in the preferred embodiment activates the reset solenoid (37). The activation of the reset solenoid disengages the mechanical latch (36) from the activation valve (34) to thereby allow the spring force to close the activation valve (34), thereby stopping the flow of oxygen between the manifold (4) and the oxygen distribution system (5). Further, the reduction in pressure within the CFCV (10) to ambient pressure allows a biasing spring to close the surge flow poppet valve (21). The reset solenoid (37) then deactivates and the CFCV (10) is ready to accept an activation signal.
The oxygen flow valve mechanism (22) has a valve stem and upper piston (24) that operates as disposed in a cylinder that communicates with the main pressure control diaphragm (25). The main pressure control diaphragm (25) is disposed in a chamber and sealably engages the chamber sidewall to create a first chamber (26) and second chamber (27). The first chamber is connected to small pressure sensing passage (40) via a pneumatically controlled surge mechanism (21) that when open allows the outlet passageway (13) pressure to be communicated to the first chamber (26). The second chamber (27) on the other side of the diaphragm (25) communicates with the high altitude bleed opening (28) that is controlled by a high altitude aneroid (30).
The surge time is controlled by the CFCV (10) by pneumatic means in that the size of the poppet (21) determines the time required to depress the poppet (21) and communicate exit port (13) pressure to the first pressure chamber (26) of the diaphragm mechanism. After activation, the full manifold (4) supply pressure enters the inlet port (12), past the opened activation valve (22) and into the outlet port (13), where this high pressure depresses the poppet valve (21) until it opens to the pressure sensing passage (40).
When opened after surge, the pressure sensing passageway (40) allows pressure buildup in the first chamber (26) that raises the spring loaded diaphragm (25) and the pressure regulating valve (22), which decreases flow and pressure. As pressure builds in the first chamber (26), gas is allowed to flow through the small orifice (39) that communicates to the second chamber (27). Additionally, flow is adjusted by operation of the altitude aneroid (30).
The design of the pressure control diaphragm (25) uses multiple springs (43) to provide greater accuracy, and also employs an additional fine adjustment screw (31). The multiple springs (43) are arranged radially around the central axis of the diaphragm (25) to provide stability, and also allows spring strength to be more accurately and precisely controlled than in the case of a larger single spring. In the preferred embodiment, the CFCV diaphragm (25) uses seven springs; six distributed radially, and one located along the central axis.
Referring to
Number | Name | Date | Kind |
---|---|---|---|
2308124 | Stettner | Jan 1943 | A |
2384669 | Fields | Sep 1945 | A |
3698412 | Smyly | Oct 1972 | A |
3960358 | Vollmer et al. | Jun 1976 | A |
3981300 | Williams | Sep 1976 | A |
4226259 | Szekely et al. | Oct 1980 | A |
4282710 | Avant | Aug 1981 | A |
4336590 | Jacq et al. | Jun 1982 | A |
4406400 | Berkhof | Sep 1983 | A |
4445532 | Mitchell | May 1984 | A |
4499914 | Schebler | Feb 1985 | A |
4506690 | Mitchell | Mar 1985 | A |
4567909 | Schebler et al. | Feb 1986 | A |
4634047 | Dean | Jan 1987 | A |
4648397 | Beale | Mar 1987 | A |
4651728 | Gupta et al. | Mar 1987 | A |
4829196 | Bronicki et al. | May 1989 | A |
4858606 | Hamlin | Aug 1989 | A |
5127436 | Campion et al. | Jul 1992 | A |
5199423 | Harral et al. | Apr 1993 | A |
5513673 | Slavin et al. | May 1996 | A |
5709204 | Lester | Jan 1998 | A |
5762102 | Rimboym | Jun 1998 | A |
5809999 | Lang | Sep 1998 | A |
5988204 | Reinhardt et al. | Nov 1999 | A |
6003543 | Sulatisky et al. | Dec 1999 | A |
6110427 | Uffenheimer | Aug 2000 | A |
6244540 | Stabile et al. | Jun 2001 | B1 |
Number | Date | Country | |
---|---|---|---|
20040216742 A1 | Nov 2004 | US |